GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicara Therapeutics Inc (NAS:BCAX) » Definitions » Dividend Payout Ratio

BCAX (Bicara Therapeutics) Dividend Payout Ratio : 0.00 (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bicara Therapeutics Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Bicara Therapeutics's Dividend Payout Ratio for the months ended in Jun. 2024 was 0.00.

The historical rank and industry rank for Bicara Therapeutics's Dividend Payout Ratio or its related term are showing as below:


BCAX's Dividend Payout Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 0.48
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-12-12), the Dividend Yield % of Bicara Therapeutics is 0.00%.

Bicara Therapeutics's Dividends per Share for the months ended in Jun. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Bicara Therapeutics Dividend Payout Ratio Historical Data

The historical data trend for Bicara Therapeutics's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bicara Therapeutics Dividend Payout Ratio Chart

Bicara Therapeutics Annual Data
Trend Dec22 Dec23
Dividend Payout Ratio
- -

Bicara Therapeutics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24
Dividend Payout Ratio - - - -

Competitive Comparison of Bicara Therapeutics's Dividend Payout Ratio

For the Biotechnology subindustry, Bicara Therapeutics's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bicara Therapeutics's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bicara Therapeutics's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Bicara Therapeutics's Dividend Payout Ratio falls into.



Bicara Therapeutics Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Bicara Therapeutics's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=0/ -3.37
=N/A

Bicara Therapeutics's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2024 )/ EPS without NRI (Q: Jun. 2024 )
=0/ -0.87
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bicara Therapeutics (NAS:BCAX) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Bicara Therapeutics Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Bicara Therapeutics's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bicara Therapeutics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
116 Huntington Avenue, Suite 703, Boston, MA, USA, 02116
Website
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.